wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36801543-EE04766B-014E-4820-82FF-595373D660E5
Q36801543-EE04766B-014E-4820-82FF-595373D660E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36801543-EE04766B-014E-4820-82FF-595373D660E5
Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.
P2860
Q36801543-EE04766B-014E-4820-82FF-595373D660E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36801543-EE04766B-014E-4820-82FF-595373D660E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ca2702e131b352b55dbf857516ef9e1a8a94e733
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.